Apheresis Equipment Sales

Apheresis Equipment Sales Market Outlook

The global apheresis equipment market is projected to reach a valuation of approximately USD 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of around 8.2% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of chronic diseases, heightened demand for blood and its components, and advancements in apheresis technologies. Furthermore, the rise in awareness regarding blood donation and the therapeutic applications of apheresis in treating various medical conditions are expected to bolster market growth. Additionally, the integration of innovative technologies and enhanced healthcare infrastructure, especially in emerging economies, is anticipated to propel the apheresis equipment market forward.

Growth Factor of the Market

Several factors contribute to the growth of the apheresis equipment market, notably the rising incidence of blood-related disorders such as hematological malignancies, autoimmune diseases, and renal diseases, which often require therapeutic apheresis procedures. Additionally, the demand for platelet and plasma donations is growing, spurred by an increase in surgical procedures and trauma cases, necessitating efficient blood management systems. The technological advancements in apheresis machines, including the development of automated systems and improvements in safety features, also play a significant role by enabling faster and more efficient procedures. Furthermore, collaborative efforts among healthcare institutions and government initiatives aimed at promoting blood donation and enhancing healthcare quality are expected to further drive market expansion. The ongoing research and development activities focusing on novel apheresis techniques are likely to create new opportunities for growth as well.

Key Highlights of the Market

• The global apheresis equipment market is projected to witness significant growth due to the increasing prevalence of chronic diseases.
• Technological advancements are leading to more efficient and safer apheresis procedures, driving market demand.
• Collaborative efforts between governments and healthcare organizations are enhancing blood donation awareness.
• Automated apheresis systems are gaining popularity, further propelling market growth.
• Emerging economies are witnessing a notable increase in healthcare infrastructure, creating new market opportunities.

By Product Type

Plasmapheresis Equipment:

Plasmapheresis equipment is one of the most essential segments within the apheresis equipment market, primarily used for the separation and removal of plasma from the blood. This equipment plays a critical role in treating various conditions such as autoimmune diseases, hyperlipidemia, and renal disorders. The growing need for plasma-derived therapies and the increasing application of plasmapheresis in clinical settings are significant factors driving the demand for this equipment. As a result, technological advancements that enhance efficiency and safety in plasmapheresis procedures continue to shape this segment’s growth trajectory.

Photopheresis Equipment:

Photopheresis equipment is specifically designed for apheresis procedures that involve the exposure of leukocytes to ultraviolet light after they have been separated from the blood. This technique is primarily employed in the treatment of certain skin disorders and hematological malignancies. The increase in the prevalence of conditions that require photopheresis, along with the ongoing research into its efficacy and applications, contributes positively to the growth of this segment. Moreover, the rising awareness among healthcare professionals regarding the benefits of using photopheresis as a treatment method is expected to bolster this market segment further.

Erythrocytapheresis Equipment:

Erythrocytapheresis equipment is utilized for the selective removal of red blood cells from the circulation, an important procedure primarily used for patients suffering from conditions such as sickle cell disease and severe anemia. The increasing incidence of these blood disorders, coupled with enhanced treatment protocols that emphasize patient-centric approaches, has driven demand for erythrocytapheresis equipment. Moreover, the advancements in technology aimed at improving the efficiency and safety of erythrocytapheresis procedures, along with growing investments in healthcare infrastructure, are major factors propelling this segment’s market growth.

Leukapheresis Equipment:

Leukapheresis equipment is essential for the separation and collection of white blood cells, which play a vital role in various therapeutic applications, including cancer treatment and stem cell transplantation. The rising number of cancer cases globally and the increasing use of leukapheresis in clinical research settings are significant factors driving the growth of this segment. Furthermore, advancements in leukapheresis technology that increase the efficiency of cell collection and minimize patient discomfort are expected to further stimulate market growth in the coming years.

Plateletpheresis Equipment:

Plateletpheresis equipment facilitates the selective separation of platelets from the blood for various transfusion and therapeutic purposes. The increasing demand for platelets in surgical procedures and the rising incidences of conditions such as thrombocytopenia are key factors driving the growth of this segment. Additionally, the growing emphasis on the importance of platelet donation and the development of technologies that enhance the collection process further support the market for plateletpheresis equipment. As healthcare professionals increasingly recognize the significance of platelets in patient care, this segment is expected to experience substantial growth.

By Application

Renal Diseases:

Apheresis equipment is increasingly used in the treatment of renal diseases, where it serves as a crucial intervention for patients suffering from conditions such as nephrotic syndrome and acute renal failure. The effectiveness of apheresis in removing harmful substances from the blood and reducing the burden on the kidneys significantly contributes to its application in this area. As the prevalence of renal diseases continues to rise globally, driven by factors such as diabetes and hypertension, the demand for apheresis procedures and corresponding equipment is expected to grow steadily.

Neurology:

In the field of neurology, apheresis is utilized as a therapeutic option for various neurological disorders, including multiple sclerosis and Guillain-Barré syndrome. Apheresis techniques such as plasmapheresis have shown efficacy in alleviating symptoms and modifying disease progression in these patients. The increasing understanding of the benefits of apheresis in neurology, along with the rising prevalence of neurological disorders, is expected to drive the growth of this application segment. Furthermore, ongoing research into novel applications of apheresis in neurology may open new avenues for its utilization, thereby spurring further growth.

Hematology:

The application of apheresis in hematology is primarily focused on managing various blood disorders, including leukemia, lymphoma, and sickle cell disease. Apheresis techniques not only assist in the removal of pathological cells but also facilitate the collection of stem cells for transplantation. The increasing incidence of hematological malignancies, coupled with advancements in apheresis technology that improve patient outcomes, is a significant factor driving this segment's growth. Additionally, the ongoing research into the role of apheresis in treating complex hematological conditions is likely to further expand this market area.

Autoimmune Diseases:

Apheresis is emerging as a crucial therapeutic method for treating autoimmune diseases, wherein it aids in the removal of autoantibodies and inflammatory mediators from the bloodstream. Conditions like systemic lupus erythematosus and rheumatoid arthritis have seen positive treatment outcomes with apheresis procedures. The rising prevalence of autoimmune diseases and growing recognition of apheresis as a viable treatment option are expected to contribute to the growth of this application segment. Furthermore, advancements in apheresis technologies that enhance efficacy and safety will likely strengthen its application in autoimmune disease management.

Others:

The 'Others' segment encompasses a range of applications for apheresis equipment, including but not limited to therapeutic uses in sepsis treatment and organ transplantation. As healthcare professionals increasingly explore the therapeutic potential of apheresis in diverse clinical scenarios, the demand for apheresis equipment in these areas is expected to grow. Moreover, ongoing clinical trials and research studies investigating novel applications of apheresis in various medical fields are likely to uncover additional opportunities for growth within this segment, thereby stimulating market expansion.

By End User

Hospitals:

Hospitals are the primary end-users of apheresis equipment, utilizing it extensively for therapeutic procedures involving patients with various medical conditions. The increasing patient population requiring apheresis treatments, along with advancements in hospital infrastructure and technology, is driving demand in this segment. Additionally, hospitals are increasingly investing in state-of-the-art apheresis machines to enhance patient care and improve clinical outcomes. As hospitals seek to provide comprehensive treatment options, the reliance on apheresis procedures is expected to continue growing.

Clinics:

Clinics specializing in outpatient care play a significant role in the apheresis equipment market, offering a range of services to patients requiring treatment. These clinics are increasingly adopting apheresis technologies to cater to the rising demand for specialized care in chronic diseases and blood disorders. The convenience of outpatient apheresis procedures and the growing preference among patients for less invasive treatments have contributed to the expansion of this segment. As more clinics incorporate apheresis services into their offerings, the overall demand for apheresis equipment is anticipated to rise.

Blood Banks:

Blood banks are critical players in the apheresis equipment market, as they rely on apheresis technologies for the efficient collection and processing of blood components. The increasing demand for blood products, particularly during surgical procedures and trauma care, has driven blood banks to invest in advanced apheresis systems. Furthermore, initiatives promoting voluntary blood donation are contributing to the growth of this segment, as blood banks aim to optimize their collection processes. As the need for a diverse range of blood products continues to grow, the role of apheresis equipment in blood banks is expected to expand significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly incorporating apheresis procedures into their services, driven by the growing demand for outpatient surgical interventions. The ability of ASCs to offer efficient and cost-effective apheresis treatments is a significant factor contributing to the growth of this segment. The trend towards minimally invasive procedures in ASCs aligns well with apheresis techniques, making them an attractive option for both providers and patients. As the number of ASCs continues to rise globally, so too will the demand for apheresis equipment within these facilities.

Others:

The 'Others' segment includes various end-users such as research laboratories and specialty clinics that utilize apheresis equipment for diverse applications. As research into the therapeutic applications of apheresis expands, laboratories are increasingly investing in advanced apheresis technologies to support clinical studies and trials. Furthermore, specialty clinics focusing on specific treatments are adopting apheresis techniques to enhance their offerings, thereby contributing to market growth. The increasing recognition of the importance of apheresis in research and specialized care is expected to drive demand in this segment.

By Technology

Centrifugation:

Centrifugation is one of the most common technologies utilized in apheresis procedures, leveraging centrifugal force to separate blood components based on their density. This technology is widely employed due to its efficiency and precision in isolating specific cellular components, such as platelets and plasma. The increasing prevalence of various blood disorders and the growing demand for blood component therapies are propelling the adoption of centrifugation technology in apheresis. Furthermore, advancements in centrifugation techniques are enhancing the safety and effectiveness of apheresis procedures, thereby driving market growth.

Membrane Filtration:

Membrane filtration technology is gaining traction in the apheresis equipment market due to its ability to selectively separate blood components based on size and molecular weight. This technology is particularly beneficial for applications requiring high purity and concentration of specific components. The rising demand for high-quality blood component products in therapeutic applications is a significant factor driving the adoption of membrane filtration technology. Additionally, ongoing innovations in membrane materials and filtration processes are expected to enhance the efficiency and effectiveness of this technology in apheresis applications.

Immunoadsorption:

Immunoadsorption technology is a specialized apheresis technique used to selectively remove specific antibodies from the bloodstream, making it a valuable option for treating autoimmune diseases and certain types of cancer. The increasing prevalence of autoimmune disorders and the growing recognition of immunoadsorption's benefits are driving demand for this technology in clinical settings. Furthermore, advancements in immunoadsorption techniques, including the development of high-capacity adsorbers, are expected to enhance its application in various therapeutic areas, thereby contributing to market growth.

Others:

The 'Others' segment encompasses various emerging technologies utilized in apheresis procedures, including newer methods such as leukapheresis and extracorporeal photopheresis. As research into novel apheresis techniques expands, there is a growing interest in exploring new technologies that enhance the efficacy and safety of apheresis. The increasing focus on patient-centered approaches in treatment is driving the exploration of innovative apheresis technologies, which may offer alternative solutions for managing various medical conditions. This segment is expected to witness significant growth as healthcare professionals continuously seek advancements in apheresis technology.

By Region

The apheresis equipment market exhibits significant regional variations, with North America leading the market due to advanced healthcare infrastructure, high expenditure on healthcare, and a well-established presence of key market players. In 2025, North America is expected to account for over 40% of the global market share, driven by the increasing prevalence of chronic diseases and the rising demand for blood components. The region's commitment to research and development, alongside favorable reimbursement policies for apheresis procedures, further strengthens its position as a dominant player in the global market. The CAGR for this region is projected to be around 7.5% during the forecast period.

Europe is the second-largest market for apheresis equipment, anticipated to hold approximately 25% of the global market share by 2025. The growth in this region is attributed to the rising incidence of hematological disorders, along with the increasing emphasis on blood donation initiatives. Furthermore, the expanding healthcare infrastructure and rising investments in advanced medical technologies are expected to foster market growth in Europe. Additionally, the Asia Pacific region is witnessing rapid growth, driven by the increasing patient population, advancements in healthcare technologies, and rising awareness of the benefits of apheresis treatments. This region is projected to record a notable CAGR of around 9% from 2025 to 2035.

Opportunities

The growing demand for blood component therapies presents significant opportunities for the apheresis equipment market. As healthcare systems worldwide increasingly recognize the therapeutic potential of apheresis in treating various medical conditions, investments in advanced apheresis technologies are likely to rise. This trend is particularly evident in emerging economies, where the increasing prevalence of chronic diseases is creating a burgeoning market for apheresis procedures. Furthermore, collaborations among healthcare organizations, research institutions, and pharmaceutical companies to innovate and improve existing apheresis technologies are expected to generate novel solutions that can enhance patient outcomes, thereby creating further growth prospects.

Moreover, the rising awareness of the importance of blood donation and the establishment of blood collection centers are expected to bolster the apheresis equipment market. As governments and healthcare organizations implement initiatives to encourage voluntary blood donations, the demand for apheresis technologies will likely surge. Additionally, the expansion of outpatient services and the increasing emphasis on patient-centric care are creating opportunities for apheresis procedures in various clinical settings. The ongoing research and clinical trials exploring the applications of apheresis in diverse medical fields will further open up avenues for market growth, driving innovations that enhance the effectiveness of apheresis treatments.

Threats

Despite the promising growth prospects for the apheresis equipment market, several threats could hinder its progress. A significant challenge stems from the high costs associated with advanced apheresis technologies and procedures, which may limit access to these treatments in resource-constrained healthcare systems. Budget constraints faced by hospitals and clinics could lead to decreased investments in apheresis equipment, ultimately impacting market growth. Additionally, complexities in regulatory approvals for new technologies may further delay the introduction of innovative apheresis solutions into the market, thereby stalling advancements that could enhance treatment outcomes.

Furthermore, the potential for complications associated with apheresis procedures, such as allergic reactions and infections, may deter healthcare providers from adopting these technologies. The lack of trained professionals equipped to handle apheresis equipment can also pose a significant barrier to market growth as proper training is essential for ensuring patient safety and effective treatment. Lastly, the ongoing impact of the COVID-19 pandemic on healthcare systems may lead to a decline in elective procedures, including apheresis, affecting overall market demand in the short term.

Competitor Outlook

• Terumo BCT
• Fresenius Kabi AG
• Haemonetics Corporation
• Hemonetics Corporation
• Graham-Field Health Products, Inc.
• Asahi Kasei Medical Co., Ltd.
• Macopharma
• BloodCenter of Wisconsin
• Charité – Universitätsmedizin Berlin
• Medtronic plc
• Vitalant
• Baxter International Inc.
• Shandong Zhongbaokang Medical Technology Co., Ltd.
• Kawasumi Laboratories, Inc.
• Mycromed
• Thermo Fisher Scientific Inc.

The competitive landscape of the apheresis equipment market is characterized by the presence of numerous established companies and emerging players. Major players such as Terumo BCT, Fresenius Kabi AG, and Haemonetics Corporation dominate the market due to their extensive product portfolios and strong distribution networks. These companies continuously invest in research and development to innovate and enhance their apheresis technologies, ensuring they remain at the forefront of the industry. Additionally, strategic partnerships and collaborations among market players are common practices aimed at expanding their market reach and leveraging complementary strengths to drive growth.

Terumo BCT, for instance, specializes in blood component technology and offers advanced apheresis equipment that facilitates the collection of platelets, plasma, and other blood components. The company's commitment to innovation is evident in its focus on developing automated systems that enhance efficiency and safety. Fresenius Kabi AG, another key player, is known for its comprehensive range of apheresis technologies, including specialized equipment for various therapeutic applications. The company’s strong presence in global markets and emphasis on high-quality products contribute to its competitive advantage.

Haemonetics Corporation is recognized for its expertise in blood management solutions and apheresis technologies, providing systems designed to optimize the collection and processing of blood components. The company’s focus on enhancing patient outcomes through innovative technologies positions it favorably within the market. Furthermore, as new players emerge and existing companies expand their offerings, the competitive dynamics within the apheresis equipment market are expected to evolve, leading to increased innovation and improved treatment options for patients worldwide.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Mycromed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vitalant
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Macopharma
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Terumo BCT
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hemonetics Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Haemonetics Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 BloodCenter of Wisconsin
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Baxter International Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Kawasumi Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Kasei Medical Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Graham-Field Health Products, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shandong Zhongbaokang Medical Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 Charité – Universitätsmedizin Berlin
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Apheresis Equipment Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Blood Banks
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Others
  • 6.2 Apheresis Equipment Sales Market, By Technology
    • 6.2.1 Centrifugation
    • 6.2.2 Membrane Filtration
    • 6.2.3 Immunoadsorption
    • 6.2.4 Others
  • 6.3 Apheresis Equipment Sales Market, By Application
    • 6.3.1 Renal Diseases
    • 6.3.2 Neurology
    • 6.3.3 Hematology
    • 6.3.4 Autoimmune Diseases
    • 6.3.5 Others
  • 6.4 Apheresis Equipment Sales Market, By Product Type
    • 6.4.1 Plasmapheresis Equipment
    • 6.4.2 Photopheresis Equipment
    • 6.4.3 Erythrocytapheresis Equipment
    • 6.4.4 Leukapheresis Equipment
    • 6.4.5 Plateletpheresis Equipment

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Apheresis Equipment Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Apheresis Equipment Sales market is categorized based on

By Product Type

• Plasmapheresis Equipment
• Photopheresis Equipment
• Erythrocytapheresis Equipment
• Leukapheresis Equipment
• Plateletpheresis Equipment

By Application

• Renal Diseases
• Neurology
• Hematology
• Autoimmune Diseases
• Others

By End User

• Hospitals
• Clinics
• Blood Banks
• Ambulatory Surgical Centers
• Others

By Technology

• Centrifugation
• Membrane Filtration
• Immunoadsorption
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Terumo BCT
• Fresenius Kabi AG
• Haemonetics Corporation
• Hemonetics Corporation
• Graham-Field Health Products, Inc.
• Asahi Kasei Medical Co., Ltd.
• Macopharma
• BloodCenter of Wisconsin
• Charité – Universitätsmedizin Berlin
• Medtronic plc
• Vitalant
• Baxter International Inc.
• Shandong Zhongbaokang Medical Technology Co., Ltd.
• Kawasumi Laboratories, Inc.
• Mycromed
• Thermo Fisher Scientific Inc.